These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26352211)

  • 61. A look around the West Indies: The spices of life are secondary metabolites.
    Demeritte A; Wuest WM
    Bioorg Med Chem; 2020 Dec; 28(23):115792. PubMed ID: 33038665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Natural products discovery from micro-organisms in the post-genome era.
    Ikeda H
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):13-22. PubMed ID: 27885932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macrolactin W, a new antibacterial macrolide from a marine Bacillus sp.
    Mondol MA; Kim JH; Lee HS; Lee YJ; Shin HJ
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3832-5. PubMed ID: 21570834
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemical dereplication of marine actinomycetes by liquid chromatography-high resolution mass spectrometry profiling and statistical analysis.
    Forner D; Berrué F; Correa H; Duncan K; Kerr RG
    Anal Chim Acta; 2013 Dec; 805():70-9. PubMed ID: 24296145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "marinispora".
    Kwon HC; Kauffman CA; Jensen PR; Fenical W
    J Am Chem Soc; 2006 Feb; 128(5):1622-32. PubMed ID: 16448135
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Strategies for the isolation and characterization of antibacterial lantibiotics.
    Jabes D; Donadio S
    Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nucleophilic 1,4-additions for natural product discovery.
    Cox CL; Tietz JI; Sokolowski K; Melby JO; Doroghazi JR; Mitchell DA
    ACS Chem Biol; 2014 Sep; 9(9):2014-22. PubMed ID: 24937678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of Natural Products Biosynthetic Pathways via a Protein Modification Level Regulation.
    Zhang B; Tian W; Wang S; Yan X; Jia X; Pierens GK; Chen W; Ma H; Deng Z; Qu X
    ACS Chem Biol; 2017 Jul; 12(7):1732-1736. PubMed ID: 28562006
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora.
    Fiedler HP; Bruntner C; Riedlinger J; Bull AT; Knutsen G; Goodfellow M; Jones A; Maldonado L; Pathom-aree W; Beil W; Schneider K; Keller S; Sussmuth RD
    J Antibiot (Tokyo); 2008 Mar; 61(3):158-63. PubMed ID: 18503194
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phylogenetic diversity and biological activity of culturable Actinobacteria isolated from freshwater fish gut microbiota.
    Jami M; Ghanbari M; Kneifel W; Domig KJ
    Microbiol Res; 2015 Jun; 175():6-15. PubMed ID: 25662514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mixed fermentation for natural product drug discovery.
    Pettit RK
    Appl Microbiol Biotechnol; 2009 May; 83(1):19-25. PubMed ID: 19305992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism.
    Craney A; Ozimok C; Pimentel-Elardo SM; Capretta A; Nodwell JR
    Chem Biol; 2012 Aug; 19(8):1020-7. PubMed ID: 22921069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Old meets new: using interspecies interactions to detect secondary metabolite production in actinomycetes.
    Seyedsayamdost MR; Traxler MF; Clardy J; Kolter R
    Methods Enzymol; 2012; 517():89-109. PubMed ID: 23084935
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigation of Interspecies Interactions within Marine Micromonosporaceae Using an Improved Co-Culture Approach.
    Adnani N; Vazquez-Rivera E; Adibhatla SN; Ellis GA; Braun DR; Bugni TS
    Mar Drugs; 2015 Sep; 13(10):6082-98. PubMed ID: 26404321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomics-Driven Natural Product Discovery in Actinomycetes.
    Niu G
    Trends Biotechnol; 2018 Mar; 36(3):238-241. PubMed ID: 29126570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biodiversity in production of antibiotics and other bioactive compounds.
    Mahajan G; Balachandran L
    Adv Biochem Eng Biotechnol; 2015; 147():37-58. PubMed ID: 24840777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current approaches to exploit actinomycetes as a source of novel natural products.
    Genilloud O; González I; Salazar O; Martín J; Tormo JR; Vicente F
    J Ind Microbiol Biotechnol; 2011 Mar; 38(3):375-89. PubMed ID: 20931260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nature Builds Macrocycles and Heterocycles into Its Antimicrobial Frameworks: Deciphering Biosynthetic Strategy.
    Walsh CT
    ACS Infect Dis; 2018 Sep; 4(9):1283-1299. PubMed ID: 29993235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibiotic production by actinomycetes: the Janus faces of regulation.
    Cundliffe E
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):500-6. PubMed ID: 16463161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.